Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Fresenius Kabi USA, LLC
EIR
•Fresenius Kabi USA, LLC•October 24, 2014

Fresenius Kabi USA, LLC – FDA EIR, Oct 24, 2014

Record Details

The FDA conducted a Good Manufacturing Practice (GMP) inspection of Fresenius Kabi USA, LLC in Grand Island, NY, from October 20-24, 2014. This was a for-cause inspection under regulatory frameworks like CPGM 7356.002A for sterile drug processes, serving as a follow-up to a February 2012 Warning Letter and an eight-item FDA-483 issued during a previous January 2013 inspection, which cited repeated violations and new deficiencies. While the firm had made significant progress in addressing prior issues, the current inspection resulted in an FDA-483 with three specific observations. Main violations included the failure to thoroughly review laboratory out-of-specification results, an inadequate incoming glass vial sampling scheme, and building design/construction flaws that allowed insect ingress and mold growth. Verbal observations highlighted inconsistent aseptic techniques, inadequate time stamps on GMP documents, and deficiencies in water sample analysis and equipment qualifications. Fresenius Kabi USA, LLC was required to submit a written response to both the FDA-483 and verbal observations within fifteen business days, with the effectiveness of corrective actions to be verified in subsequent routine inspections.

Company
Fresenius Kabi USA, LLC
Inspection date
October 24, 2014
Product type
drugs
Office
New York District Office
People
  • Sony Mathews (Consumer Safety Officer Drug Specialist)
  • Anne Huffman (company_representative)
  • James D. Bridges
  • Steven R. Nowicki (recipient)
  • Alice S. Tsao (Consumer Safety Officer at FDA)
View Company Profile

ID · f4f4b86e-d11f-4cad-a48c-58d373c8776c

Violation Codes4
21 CFR 211.42(a)21 CFR 820.10021 CFR 211.84(b)21 CFR 211.192

Full citation text and observation details available on the Dashboard.

Other documents for Fresenius Kabi USA, LLC
  • 483 - 2026-05-14May 14, 2026
  • 483 - 2023-10-13October 13, 2023
  • 483 - 2023-08-30August 30, 2023
  • 483 - 2019-08-12August 12, 2019
  • EIR - 2019-08-12August 12, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Fresenius Kabi USA, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.